Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 1, 2011, Pages 203-210

  Adesse, Daniel ^a   Azzam, Eduardo Meirelles ^a   De Meirelles, Maria Nazareth L ^a   Urbina, Julio A ^b   Garzoni, Luciana R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CONNEXIN 43; ERGOSTEROL; F ACTIN;

ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CELL PROLIFERATION; CHAGAS DISEASE; CYTOSKELETON; DRUG EFFECT; GAP JUNCTION; HEART MUSCLE CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TRYPANOSOMA CRUZI;

AMIODARONE; ANIMALS; CELLS, CULTURED; CYTOSKELETON; FLUORESCENT ANTIBODY TECHNIQUE; GAP JUNCTIONS; MICE; MYOCYTES, CARDIAC; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 78650636036     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01129-10     Document Type: Article

References (38)

1. Adesse, D., L. R. Garzoni, H. Huang, H. B. Tanowitz, M. de Nazareth Meirelles, and D. C. Spray. 2008. Trypanosoma cruzi induces changes in cardiac connexin43 expression. Microbes Infect. 10:21-28.
2. 2+ transients in isolated primary canine cardiac myocytes. Infect. Immun. 64:1770-1777.
3. Beardslee, M. A., J. G. Laing, E. C. Beyer, and J. E. Saffitz. 1998. Rapid turnover of connexin43 in the adult rat heart. Circ. Res. 21:629-635.
4. Benaim, G., J. M. Sanders, Y. Garcia-Marchán, C. Colina, R. Lira, A. R. Caldera, G. Payares, C. Sanoja, J. M. Burgos, A. Leon-Rossell, J. L. Concepcion, A. G. Schijman, M. Levin, E. Oldfield, and J. A. Urbina. 2006. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J. Med. Chem. 9:892-899.
5. Buckner, F., K. Yokoyama, J. Lockman, K. Aikenhead, J. Ohkanda, M. Sadilek, S. Sebti, W. Van Voorhis, A. Hamilton, and M. H. Gelb. 2003. A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents. Proc. Natl. Acad. Sci. U. S. A. 9:15149-15153.
6. Cançado, J. R. 2002. Long term evaluationtermevaluation of etiological treatment of Chagas disease with disease with benznidazole. Rev. Inst. Med. Trop. Sao Paulo 44:29-37.
7. Chagas, C. 1909. Nova tripanozomiaze humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen, n. sp., ajente etiolojico de nova entidade morbida do homem. Mem. Inst. Oswaldo Cruz 1:11-80.
8. Coura, J. R., and S. L. de Castro. 2002. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 97:3-24.
9. Courchesne, W. E. 2002. Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone. J. Pharmacol. Exp. Ther. 300:195-199.
10. Courchesne, W. E., M. Tunc, and S. Liao. 2009. Amiodarone induces stress responses and calcium flux mediated by the cell wall in Saccharomyces cerevisiae. Can. J. Microbiol. 55:288-303.
11. de Carvalho, A. C., H. B. Tanowitz, M. Wittner, R. Dermietzel, C. Roy, E. L. Hertzberg, and D. C. Spray. 1992. Gap junction distribution is altered between cardiac myocytes infected with Trypanosoma cruzi. Circ. Res. 70:733-742.
12. de Melo, T. G., M. N. Meirelles, and M. C. Pereira. 2008. Trypanosoma cruzi alters adherens junctions in cardiomyocytes. Microbes Infect. 10:1405-1410.
13. Docampo, R., and S. N. Moreno. 2008. The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites. Curr. Pharm. Des. 14:882-888.
14. Reference deleted.
15. Duffy, H. S., A. G. Fort, and D. C. Spray. 2006. Cardiac connexins: genes to nexus. Adv. Cardiol. 42:1-17.
16. Garzoni, L. R., A. Caldera, M. de N. Meirelles, S. L. de Castro, R. Docampo, G. A. Meints, E. Oldfield, and J. A. Urbina. 2004. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi. Int. J. Antimicrob. Agents 23:273-285.
17. 2+]i responses in primary cultures of mouse cardiomyocytes induced by Trypanosoma cruzi trypomastigotes. Mem. Inst. Oswaldo Cruz 98:487-493.
18. Garzoni, L. R., M. C. Waghabi, M. M. Baptista, S. L. de Castro, M. de N. Meirelles, C. C. Britto, R. Docampo, E. Oldfield, and J. A. Urbina. 2004. Antiparasitic activity of risedronate in a murine model of acute Chagas' disease. Int. J. Antimicrob. Agents 23:286-290.
19. Lazardi, K., J. A. Urbina, and W. de Souza. 1990. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 34:2097-2105.
20. Lin, Z., S. Holtzer, T. Schultheiss, J. Murray, T. Masaki, D. A. Fischman, and H. Holtzer. 1989. Polygons and adhesion plaques and disassembly and assembly of myofibrils in cardiac myocytes. J. Cell Biol. 108:2355-2367.
21. Mason, J. W. 1987. Amiodarone. N. Engl. J. Med. 316:455-466.
22. Meirelles, M. N. L., T. C. Araújo-Jorge, C. F. Miranda, W. DeSouza, and H. S. Barbosa. 1986. Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro. Eur. J. Cell Biol. 41:198-206.
23. Mielniczki-Pereira, A. A., C. M. Chiavegatto, J. A. López, W. Colli, M. J. Alves, and F. R. Gadelha. 2007. Trypanosoma cruzi strains, Tulahuen 2 and Y, besides the difference in resistance to oxidative stress, display differential glucose-6-phosphate and 6-phosphogluconate dehydrogenases activities. Acta Trop. 101:54-60.
24. Pereira, M. C. S., M. Costa, C. Chagas Filho, and M. N. L. Meirelles. 1993. Myofibrillar breakdown and cytoskeletal alterations in heart muscle cells during invasion by Trypanosoma cruzi: immunological and ultrastructural study. J. Submicrosc. Cytol. Pathol. 25:559-569.
25. Rassi, A., Jr., J. C. Dias, J. A. Marin-Neto, and A. Rassi. 2009. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart 95:524-534.
26. Rassi, A., Jr., A. Rassi, and W. C. Little. 2000. Chagas' heart disease. Clin. Cardiol. 23:883-889.
27. Sanchez, G., A. Wallace, M. Olivares, N. Diaz, X. Aguilera, W. Apt, and A. Solari. 1990. Biological characterization of Trypanosoma cruzi zymodemes: in vitro differentiation of epimastigotes and infectivity of culture metacyclic trypomastigotes to mice. Exp. Parasitol. 71:125-133.
28. 2+ homeostasis and biosynthesis of sterols in Leishmania mexicana. Antimicrob. Agents Chemother. 53:1403-1410.
29. Silva, D. T., M. de Nazareth S. L. de Meirelles, D. Almeida, J. A. Urbina, and M. C. Pereira. 2006. Cytoskeleton reassembly in cardiomyocytes infected by Trypanosoma cruzi is triggered by treatment with ergosterol biosynthesis inhibitors. Int. J. Antimicrob. Agents 27:530-537.
30. Taniwaki, N. N., F. S. Machado, A. R. Massensini, and R. A. Mortara. 2006. Trypanosoma cruzi disrupts myofibrillar organization and intracellular calcium levels in mouse neonatal cardiomyocytes. Cell Tissue Res. 324:489-496.
31. Tanowitz, H. B., L. V. Kirchhoff, D. Simon, S. A. Morris, L. M. Weiss, and M. Wittner. 1992. Chagas' disease. Clin. Microbiol. Rev. 5:400-419.
32. Tarleton, R. L., L. Zhang, and M. O. Downs. 1997. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasitespecific response to infected host tissue. Proc. Natl. Acad. Sci. U. S. A. 15:3932-3937.
33. Urbina, J. A. 2009. Ergosterol biosynthesis and drug development for Chagas disease. Mem. Inst. Oswaldo Cruz 104(Suppl. 1):311-318.
34. Urbina, J. A. 2010. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop. 115:55-68.
35. Urbina, J. A., and R. Docampo. 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 19:495-501.
36. Veloso, V. M., C. M. Carneiro, M. J. Toledo, M. Lana, E. Chiari, W. L. Tafuri, and M. T. Bahia. 2001. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Mem. Inst. Oswaldo Cruz 96:1005-1011.
37. Vivas, J., J. A. Urbina, and W. de Souza. 1996. Ultrastructural alterations in Trypanosoma (Schizotrypanum) cruzi induced by delta(24(25)) sterol methyl transferase inhibitors and their combinations with ketoconazole. Int. J. Antimicrob. Agents 7:235-240.
38. WHO. 2002. Control of Chagas disease. Technical reports series. 905:1-109.